Sphera Funds Management’s Larimar Therapeutics LRMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-260,385	Closed	-$841K	–	117
2025 Q3	$841K	Buy	260,385 +63,750	+32%	+$239K	0.2%	98
2025 Q2	$568K	Sell	196,635 -169,669	-46%	-$393K	0.15%	98
2025 Q1	$788K	Sell	366,304 -89,300	-20%	-$282K	0.19%	98
2024 Q4	$1.76M	Buy	455,604 +41,126	+10%	+$271K	0.33%	84
2024 Q3	$2.71M	Buy	414,478 +102,009	+33%	+$820K	0.44%	66
2024 Q2	$2.27M	Buy	+312,469	New	+$2.39M	0.37%	86
2021 Q2	–	Sell	-100,000	Closed	-$1.46M	–	163
2021 Q1	$1.46M	Buy	+100,000	New	+$1.82M	0.13%	132
2020 Q4	–	Sell	-342,064	Closed	-$5.19M	–	127
2020 Q3	$5.19M	Sell	342,064 -54,723	-14%	-$693K	0.6%	58
2020 Q2	$5.1M	Buy	396,787 +133,323	+51%	+$1.55M	0.61%	52
2020 Q1	$2.43M	Buy	263,464 +234,491	+809%	+$3.08M	0.4%	51
2019 Q4	$386K	Buy	+28,973	New	+$277K	0.05%	84
2019 Q1	–	Sell	-31,667	Closed	-$1.88M	–	115
2018 Q4	$1.88M	Sell	31,667 -4,166	-12%	-$411K	0.27%	76
2018 Q3	$5.03M	Sell	35,833 -4,167	-10%	-$506K	0.66%	47
2018 Q2	$4.91M	Buy	+40,000	New	+$3.4M	0.78%	40
2015 Q4	–	Sell	-3,333	Closed	-$1.28M	–	125
2015 Q3	$1.28M	Buy	+3,333	New	+$1.5M	0.23%	112
2015 Q1	–	Sell	-6,008	Closed	-$2.22M	–	160
2014 Q4	$2.22M	Sell	6,008 -2,084	-26%	-$537K	0.39%	83
2014 Q3	$1.91M	Buy	+8,092	New	+$1.83M	0.29%	92